ALNY - ALNYLAM PHARMACEUTICALS, INC.
320.66
0.150 0.047%
Share volume: 983,222
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$320.51
0.15
0.00%
Summary score
52%
Profitability
47%
Dept financing
41%
Liquidity
75%
Performance
55%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-2.32%
Return on sales
-26.07%
Return on invested capital
0%
Total debt ratio
99.6%
Debt ratio change over timeo
-1.48%
Current Ratio
3.19%
Quick Ratio
3.09%
Cash Position Ratio
0.96%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
2.55%
Return on sales
10.6%
Return on invested capital
0%
Total debt ratio
92.77%
Debt ratio change over timeo
0%
Current Ratio
2.79%
Quick Ratio
2.73%
Cash Position Ratio
0.97%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
5.38%
Return on sales
12.01%
Return on invested capital
0%
Total debt ratio
84.11%
Debt ratio change over time
0%
Current Ratio
2.76%
Quick Ratio
2.71%
Cash Position Ratio
1.13%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-96.9%
Return on sales
-62.99%
Return on invested capital
0%
Total debt ratio
-147.5%
Debt ratio change over time
-1.48%
Current Ratio
-3.3%
Quick Ratio
-3.23%
Cash Position Ratio
-1.47%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALNY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 12.23% | 10.41% | 0% |
| Return on assets | -2.32% | 4.74% | 3.19% | 1.73% |
| Return on sales | -26.07% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 0% | 8.04% | 10.95% | 0% |
| Profitability | 0% | 93% | 84% | 29% |
| Total debt ratio | 99.6% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -1.48% | -20.57% | -85.61% | 17.33% |
| Dept financing | 25% | 20% | 15% | 49% |
| Current Ratio | 2.79% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 2.73% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.97% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 21% | 30% | 19% |
| Short-term ratios | ALNY | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | 2.55% | 6.06% | 4.18% | 1.7% |
| Return on sales | 10.6% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 67% | 50% | 34% | 23% |
| Total debt ratio | 92.77% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 48% | 20% | 15% | 25% |
| Current Ratio | 2.79% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 2.73% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 0.97% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 27% | 29% | 16% |